Close

Industry Updates

Early detection of increased thrombosis risk

Siemens Healthcare has developed Innovance Antithrombin, a new test for determining congenital and acquired antithrombin deficiency. Insufficient levels of protein in blood can lead to increased thrombophilia. Reason: Antithrombin ensures balanced blood coagulation by reducing the activity of thrombin...

Philips leads European“SonoDrugs”project to develop image-guided localized drug delivery technology

Royal Philips Electronics today announced that it is leading a major new European project to develop drug delivery technologies that could significantly impact the treatment of cancer and cardiovascular disease. By allowing drugs to be delivered to disease sites...

Cancer patients in Sweden and Estonia receive faster, more Precise Radiation Therapy treatments

Installation of the new Elekta Synergy ® systems from Elekta will enable the three university hospitals to begin treating patients with Elekta VMAT (Volumetric Modulated Arc Therapy), a new treatment technology that offers shortened treatment times with the highest...

Pioneering Cancer Center Introduces Varian RapidArc Treatments for Cancer Patients in Germany

Three prostate cancer patients have become the first people in Germany to be treated using a new, faster form of radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Sudharz Krankenhaus in...

BSD-2000 Hyperthermia System Installed at Long Beach Memorial Medical Center

BSD Medical Corporation reported that a BSD-2000 hyperthermia system purchased by the Todd Cancer Institute at Long Beach Memorial Medical Center, Department of Radiation Oncology, has been installed for participation in ongoing clinical investigations of the use of deep...

Ottawa paramedic service awards Zoll a thrid contract as preferred vendor for defibrillators

ZOLL Medical Corporation , a manufacturer of resuscitation devices and elated software solutions, announced today that Ottawa Paramedic Service (OPS), which provides emergency medical services to the Canadian capital city of Ottawa, Ontario, has awarded ZOLL over a $2...

Zoll receives clearance to market new R series BLS and R series plus debibrillators

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the new ZOLL R Series® BLS and R Series Plus defibrillators....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read